Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Benner

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|February 10, 2021
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemiaCécile Pautas, Emmanuel Raffoux, Juliette Lambert, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Molecular & General Genetics : MGG|December 23, 1998
Cloning and expression of the ApaLI, NspI, NspHI, SacI, ScaI, and SapI restriction-modification systems in Escherichia coliS Y Xu, J P Xiao, L Ettwiller, et al.
Gene|June 19, 1997
Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing elementS Chong, F B Mersha, D G Comb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerC Manegold, N van Zandwijk, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2014
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancerG V Scagliotti, I Bondarenko, F Blackhall, et al.
Haematologica|August 5, 2018
Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trialJuliette Lambert, Cécile Pautas, Christine Terré, et al.
Human Molecular Genetics|August 28, 2007
A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failureStephen B Liggett, Reagan J Kelly, Rohan R Parekh, et al.
The British Journal of Ophthalmology|August 14, 2021
Associations between systemic health and retinal nerve fibre layer thickness in preterm infants at 36 weeks postmenstrual ageLiangbo L Shen, Shwetha Mangalesh, Suzanne M Michalak, et al.
Science Signaling|October 12, 2017
Temperature-activated ion channels in neural crest cells confer maternal fever-associated birth defectsMary R Hutson, Anna L Keyte, Miriam Hernández-Morales, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|February 10, 2021
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemiaCécile Pautas, Emmanuel Raffoux, Juliette Lambert, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Molecular & General Genetics : MGG|December 23, 1998
Cloning and expression of the ApaLI, NspI, NspHI, SacI, ScaI, and SapI restriction-modification systems in Escherichia coliS Y Xu, J P Xiao, L Ettwiller, et al.
Gene|June 19, 1997
Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing elementS Chong, F B Mersha, D G Comb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerC Manegold, N van Zandwijk, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2014
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancerG V Scagliotti, I Bondarenko, F Blackhall, et al.
Haematologica|August 5, 2018
Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trialJuliette Lambert, Cécile Pautas, Christine Terré, et al.
Human Molecular Genetics|August 28, 2007
A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failureStephen B Liggett, Reagan J Kelly, Rohan R Parekh, et al.
The British Journal of Ophthalmology|August 14, 2021
Associations between systemic health and retinal nerve fibre layer thickness in preterm infants at 36 weeks postmenstrual ageLiangbo L Shen, Shwetha Mangalesh, Suzanne M Michalak, et al.
Science Signaling|October 12, 2017
Temperature-activated ion channels in neural crest cells confer maternal fever-associated birth defectsMary R Hutson, Anna L Keyte, Miriam Hernández-Morales, et al.
Pageof 11